Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmAthene
Annapolis, Maryland, United Statespharmathene.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
PharmAthene developed medical countermeasures for biological and chemical threats, including recombinant anthrax vaccines, bioscavengers for nerve agent exposure, and fully human monoclonal antibodies against anthrax. Its lead programs received significant U.S. government funding and some were on FDA fast track status. The company merged with Altimmune in 2017 to form a diversified immunotherapeutics firm targeting infectious diseases.[1][2][4][5][6]
- Therapeutic areas
- NeurologyInfectious Diseases
- Modalities
- Monoclonal antibodies (mAbs)Recombinant proteinsVaccines[2][5]
- Industry
- Biotech
02
Partnerships
Mederex Inc. (co-development partner for Valortim®)[1]U.S. Department of Defense / BARDA / NIAID – major government contracts/funding partners for product development [1][4]
Beyond the preview
Go deeper on PharmAthene.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PharmAthene.